Sirius (Cannabis flos S-LAB): leading caryophyllene and undisclosed lineage

• Who supplies it. Exclusively S-LAB, so there is nothing to compare versions with, and a supply break means the absence of this strain, not another version of it.
• Profile. Caryophyllene leads, alongside bisabolol, humulene, limonene, linalool, myrcene, nerolidol, pinene. We do not provide percentage shares because sources count them against different totals.
• Origin. Lineage undetermined. This is a result, not a gap to fill: we do not add parents based on name similarity.
• What is missing. The profile describes one source, so there is nothing to compare it with.

What is Sirius and where does this strain come from?

Sirius is an indica-dominant strain supplied to Polish pharmacies by S-LAB. Its origin cannot be provided: in the lineage graph of this compilation, its parents are marked as unknown because the breeder has not disclosed them, and available descriptions do not indicate any pair of parental strains. The name of the star is not a genetic clue here.

An empty lineage can be a result, not a gap in the query. In a compilation of 85 cultivars, as many as 25 have no established origin, and there are two reasons: either the breeder never provided a parental pair, or circulating descriptions provide conflicting pairs, and none of them has priority. Writing in parents by intuition creates a false connection in such a graph, which then travels further, as once added kinship begins to be cited by subsequent services as an establishment.

Caution is required with the name itself. Under the name Sirius, there was another position in Polish circulation, but from a different producer, and it happens to have a described origin: sources indicate a cross of Chemdawg with Alien Tech, and Sirius is there a trade name given to a strain previously known as Alien Dawg. The common word in the name does not transfer genetics in either direction, and that position is discussed in a separate entry. However, the declared genetics are consistent between both, although it comes from a commercial description, not from laboratory analysis.

Which producers have this strain in Polish pharmacies?

One: S-LAB. The name Sirius appears in Polish pharmacy circulation also with a second registration position, but it is led by a different producer and treats it as a separate cultivar because it has its own origin and its own description. At the time of data collection, neither was marked as available.

We intentionally removed the numerical suffix from both registration names. For the S-LAB position, which is the strain described on this page, the THC content is in the range of 19.8-24.2%. The Tilray position declares its own, lower value and has a separate entry in this compilation, so its numbers are not added here. The dried material is plant material, not a tablet measured on a scale, so the number entered in the name without a margin of one-tenth in either direction promises precision that the batch of raw material does not have.

Availability changes in a rhythm that is not visible from the name alone: the permit pertains to a specific batch of a specific producer, not the strain in general, so the same name can disappear from pharmacies for several months and return under a changed registration position. The database from which the profile comes marked both positions as unavailable. The current state is checked in the pharmacy, and a list of positions currently on the market is maintained by the overview of available strains. The producer has 38 names in this compilation and is described in a separate discussion. This raw material should not be confused with the dried material from the retail category, which does not follow the same dispensing procedure.

What does Sirius smell and taste like?

• bisabolol bisabolol
• humulene humulene
• caryophyllene caryophyllene (leading in the pharmacy list)
• limonene limonene
• linalool linalool
• myrcene myrcene
• nerolidol nerolidol
• pinene pinene

The source description attributes a minty, fruity, and peppery note to this position, with the peppery accent agreeing with the leading terpene in the profile. However, these are labels from the catalog, not results from sensory analysis, so they speak more about how the seller organizes the assortment than about the smell of a specific batch.

In the profile of this strain, one source lists eight compounds: bisabolol, humulene, caryophyllene, limonene, linalool, myrcene, nerolidol, and pinene. We present them as ingredients, without shares, and the reason is numerical, not stylistic. The values entered for these eight positions sum to 97 for one registration version and to 99 for the other, not to one hundred, so it is unclear what the missing remainder is or what the denominator refers to. Since it is unknown what constitutes the whole here, such a number measures nothing and only makes the catalog description resemble a laboratory result.

The same name receives a completely different set of scent descriptions for the second position: camphoraceous, spicy, piney, with the same pepper in the background. Since both positions have an identical list of compounds in the database, and the scent description is different, the difference was made by someone describing the product, not the plant. The smell shifts along the way, as drying, storage conditions, and the age of the batch change the proportions of volatile components, and an open package smells differently after a week than on the day of release. The strength of action says nothing about the sense of smell.

How long does it take for Sirius to take effect and how long does it last?

The route of administration determines this, not the name itself. Inhalation from a vaporizer gives the first sensations within a few minutes and ends the same evening, while an ingested portion responds much later and lasts longer. For Sirius as a single cultivar, no one has published such a measurement, so the following description pertains to routes of administration.

The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, because pharmacokinetic studies for a single cultivar have not been published.

The difference between the two positions bearing this name concerns the declared potency, not the course over time: the manufacturer’s margin shifts the value by one-tenth in either direction, while the moment of sensation onset remains where it is set by the route of administration. The method of taking the raw material is determined by the attending physician.

What has been shown about the effects of this strain, and what is the seller’s description?

Very little has been shown, and not on this strain. The evidence base for this project has two studies for caryophyllene, both on mice, both about pain and inflammation. Everything circulating about Sirius as a whole comes from catalog descriptions or patient reports, not from studies on this cultivar.

Neither of the two studies tested caryophyllene on humans or in inhaled form from dried material; both studies concern oral or systemic administration in mice in pain and inflammation models, not sleep or mood. The boundary thus lies along the model and route of administration, not just the number of studies.

What side effects have been reported from this strain?

None attributed to this name. The Polish reporting system links symptoms to the medicinal product and batch number, not to the cultivar, so there is no public compilation allowing us to write what has been reported specifically for Sirius. Below is what is known about cannabis flower as a group of raw materials.

Reports of adverse effects are collected for the medicinal product with a batch number, not for the strain name, so the following pertains to cannabis flower as a group of raw materials. The most commonly reported symptoms are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically because public compilations for cannabis flower in Poland do not separate them by individual products.

In Poland, the Office for Registration of Medicinal Products and the entity responsible for a given preparation accepts reports, and the form bears the name of the product from the packaging, not the cultivar name from the commercial description. Therefore, even after years of the strain being on the market, no statistics for the name itself are generated.

What is known about vaporizing flower with this profile?

Less than popular tables suggest. The boiling point of a terpene is not a threshold beyond which the compound begins to vaporize, and the setting on the vaporizer is not the temperature of the dried material itself. For the profile of Sirius, there is one more thing: public data on boiling are very uneven for its eight components.

Checking the PubChem database, which the project performed for eleven terpenes, yields the following for this profile: caryophyllene, limonene, linalool, myrcene, and pinene have their boiling points given along with the measurement pressure; humulene has a measurement only under reduced pressure, 99-100 degrees at 3 mm Hg, almost in a vacuum; nerolidol has a number without specified pressure; bisabolol has none in the database. Compiling such values in one column gives a table that looks comparable, but is not.

This does not result in any recommendation, and it is intentionally not present here: the method of taking the raw material is determined by the attending physician, and pharmacy flower is dispensed by prescription. Why vaporization begins below boiling is broken down in a separate entry on vaporization of terpenes, and where the discrepancies between tables come from is explained in the discussion of their comparability. Caryophyllene itself, the leading terpene in this profile, has its own discussion on the state of research.

Which strains from the pharmacy are related to Sirius?

None. In the lineage graph of this compilation, Sirius does not appear on the parent side of any of the 85 cultivars, and its own parental pair remains undetermined, so there is nothing to derive siblings from. The kinship field in the assignment is empty, and this is a reading of the data, not a gap to fill.

However, the data shows the proximity of names without kinship. The same name is borne by a position from a second producer, for which sources provide parents, and this one compilation shows that a common word is not enough: if the name proved anything, both positions would have the same lineage, and one has it, the other does not.

The second mechanism is visible on the parent side throughout the compilation. The most frequently entered parental pairs are broad families, not individual plants: og kush appears as a parent of four cultivars, afghani and white widow three times each. Two strains sharing only such an ancestor are not siblings because under that name lies a whole group, not an identified individual. An empty kinship list can therefore be a correct answer in this graph even where the lineage is known, and with Sirius, whose parents have not been provided by anyone, there can be no other answer. The entire graph and other positions from pharmacies are collected in the overview of strains available in Poland.

Frequently asked questions about the Sirius strain

Is Sirius an indica strain?

Yes. Both registration descriptions bearing this name classify the genetics as indica, and in this respect, the sources do not differ. However, the assessment comes from the commercial description, not from genetic analysis.

What is the THC content in Sirius?

For the S-LAB position, it is in the range of 19.8-24.2%. The producer provides one nominal value, and the range comes from a margin of one-tenth in either direction. The Tilray position with the same trade name has its own declaration and its own entry.

Which terpene leads the profile of this strain?

Caryophyllene. The source lists seven other compounds alongside it, but caryophyllene has the highest share in this compilation. We do not provide shares numerically because the values entered in the database do not sum to one hundred and it is unclear what they refer to.

Is it known which strains gave rise to Sirius?

No. None of the available sources provide a parental pair for this position, and in this compilation, 25 out of 85 cultivars are in the same situation. Guessing parents by name creates false connections, so the field remains empty.

Is Sirius available in Polish pharmacies?

This is changing. The database from which the profile comes marked both positions as unavailable at the time of data collection, and permits pertain to individual batches, not the strain as such. The current state is checked in the pharmacy.

Is Sirius and Tilray Sirius the same strain?

No. The only commonality is the trade name. The position from the second producer has a described origin and a separate entry in this compilation, while Sirius from S-LAB has no established parents, so the project treats them as two different cultivars.

Cannabis flower is a pharmaceutical raw material dispensed by prescription in the Rpw category. The material is informational in nature and does not replace consultation with the attending physician or pharmacist’s advice.

Editorial text: ubucha.pl editorial team.